查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629263

周邊干預市場，按產品類型、程序、最終用途、國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Peripheral Interventions Market, By Product Type, By Procedure, By End-Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 384 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2024年外圍干預市場規模為96.7834億美元，2025年至2032年複合年成長率為9.1%。

外圍干預市場-市場動態

血管疾病盛行率上升推動市場成長

血管疾病盛行率的上升是推動周邊干預市場成長的重要因素。由於人口老化、久坐的生活方式以及糖尿病、吸煙和高血壓等危險因素的增加，包括周邊動脈疾病（PAD）、靜脈曲張和深部靜脈栓塞（DVT）在內的血管疾病變得越來越常見。據世界衛生組織 (WHO) 稱，心血管疾病 (CVD) 是全球死亡的主要原因，估計佔所有死亡的 32%，其中很大一部分歸因於周邊血管疾病。隨著血管疾病變得越來越普遍，對有效、微創治療方案的需求也日益成長。支架、血管成形球囊和導管等周邊介入設備提供了一種解決方案，可實現快速、精確的治療，改善血流、緩解症狀並預防截肢或中風等嚴重併發症。隨著醫療保健系統致力於解決日益增加的血管疾病負擔，預計對這些干預措施的需求將會增加。此外，醫療技術的進步不斷使周邊干預變得更安全、更有效、侵入性更小，進一步推動了這些設備在血管疾病治療中的採用。盛行率的增加和醫療創新的結合預計將在未來幾年推動周邊干預市場的顯著成長。

外圍干預市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032 年）每年將以 9.1% 左右的複合年成長率成長
  • 根據產品類型細分，預計支架將在 2024 年呈現最大市場佔有率
  • 根據最終用途細分，醫院將成為 2024 年的主導職能
  • 按地區分類，北美是 2024 年的主要收入來源

外圍干預市場細分分析：

全球周邊干預市場根據產品類型、程序、最終用途和地區進行細分。

根據產品類型，市場分為五類：支架、導管、導絲、球囊和血管閉合裝置。支架在市場上佔據主導地位，因為它們已被證明可以透過保持動脈暢通來恢復血流，這使其成為周邊動脈疾病 (PAD) 等疾病的關鍵解決方案。此外，藥物洗脫支架和生物可吸收支架等支架技術的進步提高了它們的安全性、性能和患者治療效果，推動了它們的廣泛採用。

根據最終用途，市場分為三類：醫院、專科診所和門診手術中心。醫院憑藉其先進的醫療基礎設施、專業的電生理學實驗室以及處理複雜和大容量手術的能力而佔據市場主導地位。此外，醫院提供全面的護理，包括術前和術後監測，使其成為需要周邊介入治療的患者的首選場所。

外圍干預市場 - 地理洞察

北美擁有最大的市場佔有率，主要是由於血管疾病的高盛行率、人口老化和先進的醫療基礎設施。尤其是在對微創手術的高需求和醫療技術不斷進步的推動下，美國擁有完善的周邊干預市場。

歐洲在市場上也發揮著至關重要的作用，德國、英國和法國等國家專注於採用創新的外圍干預設備。歐洲市場受益於強力的醫療保健政策、人們對血管疾病的認知不斷提高以及先進治療方法的普及。相較之下，在中國、印度和日本等國家龐大的患者群體、改善的醫療設施以及可支配收入增加的推動下，亞太地區正在經歷最快的成長。隨著這些國家與生活方式相關的疾病盛行率上升，對具有成本效益的微創治療方案的需求不斷成長。在拉丁美洲、中東和非洲，隨著醫療保健系統的改善和對血管疾病的意識提高，周邊干預市場正在逐漸擴大，為這些地區的市場成長和創新創造了新的機會。

周邊介入市場-競爭格局：

周邊干預市場競爭格局的特點是既有多家老牌企業，也有專注於創新和新產品開發的新興公司。市場參與者基於產品品質、技術進步和策略合作夥伴關係進行競爭。領先的公司不斷致力於增強其產品系列，包括藥物洗脫支架、生物可吸收支架和先進的導管技術等功能，以改善患者的治療效果並降低併發症的風險。這些創新旨在為治療周邊血管疾病提供更安全、更有效、更持久的解決方案。此外，公司還透過合併、收購以及與醫療機構的合作來擴大其市場佔有率，以擴大其地理覆蓋範圍並接觸新的患者群體。另一個關鍵策略是強調具有成本效益的解決方案，特別是在新興市場，在這些市場中，負擔能力和可近性是推動採用的關鍵因素。監管批准和遵守嚴格的安全標準也是這一競爭格局中的關鍵差異化因素，因為公司必須適應複雜的監管環境才能推出新產品。正在進行的臨床試驗、研究和開發活動進一步塑造了競爭動態，這些活動的重點是增強設備性能和擴大周邊干預的適應症。隨著全球對先進微創治療的需求不斷成長，尤其是在血管疾病負擔日益嚴重的地區，這種情況仍在不斷發展。

最新進展：

  • 2024 年4 月，雅培突破性的可溶性支架Esprit BTK 系統獲得FDA 批准用於治療膝蓋以下動脈，為患有慢性肢體威脅性缺血(CLTI) 和外周動脈疾病(PAD) 的患者提供了一種新的有效解決方案。這種創新裝置會隨著時間的推移而溶解，在改善結果和減少疾病進展方面優於傳統的球囊血管成形術。
  • 2024 年 6 月，飛利浦推出了 Duo 靜脈支架系統，這是一種突破性的醫療設備，旨在治療慢性靜脈功能不全 (CVI) 患者的症狀性靜脈流出阻塞。該裝置已獲得 FDA 的上市前批准，透過結合 Duo Hybrid 和 Duo Extend 兩種支架來解決靜脈解剖學的挑戰，提供差異化設計以適應血管曲率並最大限度地減少支架併發症。該系統是飛利浦透過創新血管技術增強 CVI 治療的更廣泛策略的一部分。
  • 2024年11月，新的血管支架移植公司Solaris Endoangio在美國成立。該公司正在推出創新技術，旨在改善周邊動脈疾病（PAD）治療和透析通路的患者預後。此次發布標誌著一個重要的里程碑，因為 Solaris 旨在解決血管護理方面的關鍵差距，並專注於高品質、持久的解決方案，以防止再狹窄和改善長期血管通暢。

目錄

第1章：外圍干預市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的外圍干預市場片段
    • 按程序分類的外圍干預市場片段
    • 按最終用途分類的外圍干預市場片段
    • 按國家/地區分類的周邊干預市場片段
    • 按地區分類的周邊干預市場片段
  • 競爭洞察

第 3 章：外圍干預主要市場趨勢

  • 外圍干預市場促進因素
    • 市場促進因素的影響分析
  • 外圍干預市場限制
    • 市場限制影響分析
  • 外圍干預市場機會
  • 周邊干預市場未來趨勢

第 4 章：外圍干預產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：外圍干預市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：外圍干預市場格局

  • 2024 年外圍干預市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：外圍干預市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 支架
    • 導管
    • 導絲
    • 氣球
    • 血管閉合裝置

第 8 章：外圍干預市場 - 按程序

  • 概述
    • 按程序分類的細分市場佔有率分析
    • 血管成形術
    • 支架置入術
    • 旋切術
    • 溶栓

第 9 章：外周干預市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫院
    • 門診手術中心 (ASC)
    • 專科診所

第 10 章：外圍干預市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 周邊設備介入措施北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按程序）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 周邊設備干預措施歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按程序）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 周邊設備介入措施 亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 按程序分類的亞太地區市場規模和預測
    • 亞太地區市場規模和預測（按最終用途）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 外圍干預措施 拉丁美洲的主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按程序）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 周邊干預 中東和非洲主要製造商
    • MEA 市場規模和預測（按國家/地區）
    • MEA 市場規模和預測（按產品類型）
    • MEA 市場規模和預測（按程序）
    • MEA 市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 外圍干預產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott
    • Boston Scientific
    • Medtronic
    • Cook Medical
    • Cordis
    • Terumo Corporation
    • Johnson & Johnson
    • Teleflex
    • B. Braun Melsungen
    • Penumbra, Inc.
    • Endologix
    • Merit Medical Systems
    • Philips Healthcare
    • AngioDynamics
    • Siemens Healthineers
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4561

REPORT HIGHLIGHT

Peripheral Interventions Market size was valued at US$ 9,678.34 Million in 2024, expanding at a CAGR of 9.1% from 2025 to 2032.

Peripheral interventions refer to medical procedures that target the peripheral arteries, veins, or nerves outside the central body organs such as the brain and heart. These interventions typically involve minimally invasive techniques to treat conditions like peripheral artery disease (PAD), deep vein thrombosis (DVT), varicose veins, and other vascular disorders. They can include the use of devices such as stents, angioplasty balloons, catheters, or embolization coils, which are inserted into the body through small incisions or punctures. The need for peripheral intervention devices arises due to the increasing prevalence of lifestyle-related diseases such as diabetes, hypertension, and smoking, which contribute to vascular disorders. These devices help in restoring normal blood flow, alleviating symptoms, and improving the overall quality of life for patients. Peripheral interventions also offer several benefits over traditional open surgeries, including reduced recovery times, fewer complications, and minimal scarring. The importance of peripheral intervention devices lies in their ability to offer non-surgical, effective solutions to patients with vascular issues. By enabling quick intervention and precise treatment, these devices play a critical role in managing chronic conditions, preventing more serious complications like amputations or strokes, and improving patient outcomes in both short-term and long-term healthcare settings.

Peripheral Interventions Market- Market Dynamics

Rising Prevalence of vascular diseases to drive market growth

The rising prevalence of vascular diseases is a significant factor driving the growth of the peripheral interventions market. Vascular diseases, including peripheral artery disease (PAD), varicose veins, and deep vein thrombosis (DVT), are becoming more common due to an aging population, sedentary lifestyles, and an increase in risk factors such as diabetes, smoking, and hypertension. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for an estimated 32% of all deaths, with a significant portion attributed to peripheral vascular disorders. As vascular diseases become more widespread, there is a growing need for effective, minimally invasive treatment options. Peripheral intervention devices, such as stents, angioplasty balloons, and catheters, offer a solution by enabling quick and precise treatment that improves blood flow, alleviates symptoms, and prevents severe complications like limb amputations or strokes. The demand for these interventions is anticipated to rise as healthcare systems aim to address the rising burden of vascular diseases. In addition, advancements in medical technology continue to make peripheral interventions safer, more effective, and less invasive, further boosting the adoption of these devices in the treatment of vascular conditions. This combination of increasing prevalence and medical innovation is expected to drive significant growth in the peripheral interventions market in the coming years.

Peripheral Interventions Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2025-2032)
  • Based on Product Type segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-Use segmentation, Hospitals was the leading Function in 2024
  • Based on region, North America was the leading revenue generator in 2024

Peripheral Interventions Market- Segmentation Analysis:

The Global Peripheral Interventions Market is segmented based on Product Type, Procedure, End-Use and Region.

The market is divided into five categories based on Product Type: Stents, Catheters, Guidewires, Balloons, and Vascular Closure Devices. Stents dominate the market due to their proven effectiveness in restoring blood flow by keeping arteries open, making them a critical solution for conditions like peripheral artery disease (PAD). Additionally, advancements in stent technology, such as drug-eluting and bioresorbable stents, have enhanced their safety, performance, and patient outcomes, driving their widespread adoption.

The market is divided into three categories based on End-Use: Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Hospitals dominate the market due to their advanced medical infrastructure, availability of specialized electrophysiology labs, and ability to handle complex and high-volume procedures. Additionally, hospitals provide comprehensive care, including pre-and post-procedure monitoring, making them the preferred setting for patients requiring peripheral intervention treatments.

Peripheral Interventions Market- Geographical Insights

North America holds the largest market share, primarily due to the high prevalence of vascular diseases, the ageing population, and advanced healthcare infrastructure. The U.S., in particular, has a well-established market for peripheral interventions, driven by a high demand for minimally invasive procedures and ongoing advancements in medical technologies.

Europe also plays a crucial role in the market, with countries like Germany, the UK, and France focusing on the adoption of innovative peripheral intervention devices. The European market benefits from strong healthcare policies, increasing awareness of vascular diseases, and expanding access to advanced treatments. In contrast, the Asia Pacific region is experiencing the fastest growth, fueled by a large patient population, improving healthcare facilities, and increasing disposable incomes in countries like China, India, and Japan. As the prevalence of lifestyle-related diseases rises in these nations, there is a growing demand for cost-effective, minimally invasive treatment options. In Latin America and the Middle East & Africa, the peripheral interventions market is gradually expanding, as healthcare systems improve and awareness of vascular conditions increases, creating new opportunities for market growth and innovation in these regions.

Peripheral Interventions Market- Competitive Landscape:

The competitive landscape of the peripheral interventions market is characterized by the presence of several established players, alongside emerging companies focusing on innovation and new product development. Market participants compete based on product quality, technological advancements, and strategic partnerships. Leading companies are continually working to enhance their product offerings with features such as drug-eluting stents, bioresorbable stents, and advanced catheter technologies to improve patient outcomes and reduce the risk of complications. These innovations aim to provide safer, more effective, and longer-lasting solutions for treating peripheral vascular diseases. Additionally, companies are expanding their market presence through mergers, acquisitions, and collaborations with healthcare institutions to increase their geographical reach and access new patient populations. Another key strategy is the emphasis on cost-effective solutions, particularly in emerging markets, where affordability and accessibility are critical factors in driving adoption. Regulatory approvals and compliance with stringent safety standards are also key differentiators in this competitive landscape, as companies must navigate complex regulatory environments to introduce new products. The competitive dynamics are further shaped by ongoing clinical trials, research, and development activities, which focus on enhancing device performance and expanding the indications for peripheral interventions. This landscape continues to evolve as the demand for advanced, minimally invasive treatments rises globally, particularly in regions with a growing burden of vascular diseases.

Recent Developments:

  • In April 2024, Abbott's breakthrough dissolving stent, the Esprit BTK System, received FDA approval for treating arteries below the knee, offering a new, effective solution for patients with chronic limb-threatening ischemia (CLTI) and peripheral artery disease (PAD). This innovative device, which dissolves over time, outperforms traditional balloon angioplasty in improving outcomes and reducing disease progression.
  • In June 2024, Philips launched the Duo Venous Stent System, a groundbreaking medical device designed to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI). This device, which received premarket approval from the FDA, addresses challenges in venous anatomy by combining two stents, Duo Hybrid and Duo Extend, offering a differential design to accommodate vessel curvature and minimize stent complications. The system is part of Philips' broader strategy to enhance CVI treatment through innovative vascular technologies.
  • In November 2024, Solaris Endovascular, a new vascular stent graft company, was launched in the United States. The company is introducing innovative technologies aimed at improving patient outcomes in the treatment of peripheral artery disease (PAD) and dialysis access. The launch marks a significant milestone as Solaris aims to address critical gaps in vascular care, with a focus on high-quality, durable solutions to prevent restenosis and improve long-term vessel patency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIPHERAL INTERVENTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Boston Scientific
  • Medtronic
  • Cook Medical
  • Cordis
  • Terumo Corporation
  • Johnson & Johnson
  • Teleflex
  • B. Braun Melsungen
  • Penumbra, Inc.
  • Endologix
  • Merit Medical Systems
  • Philips Healthcare
  • AngioDynamics
  • Siemens Healthineers
  • Others

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Catheters
  • Guidewires
  • Balloons
  • Vascular Closure Devices

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Stenting
  • Atherectomy
  • Thrombolysis

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics

GLOBAL PERIPHERAL INTERVENTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peripheral Interventions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peripheral Interventions Market Snippet by Product Type
    • 2.1.2. Peripheral Interventions Market Snippet by Procedure
    • 2.1.3. Peripheral Interventions Market Snippet by End-Use
    • 2.1.4. Peripheral Interventions Market Snippet by Country
    • 2.1.5. Peripheral Interventions Market Snippet by Region
  • 2.2. Competitive Insights

3. Peripheral Interventions Key Market Trends

  • 3.1. Peripheral Interventions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peripheral Interventions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peripheral Interventions Market Opportunities
  • 3.4. Peripheral Interventions Market Future Trends

4. Peripheral Interventions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peripheral Interventions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Peripheral Interventions Market Landscape

  • 6.1. Peripheral Interventions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peripheral Interventions Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Catheters
    • 7.1.4. Guidewires
    • 7.1.5. Balloons
    • 7.1.6. Vascular Closure Devices

8. Peripheral Interventions Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Stenting
    • 8.1.4. Atherectomy
    • 8.1.5. Thrombolysis

9. Peripheral Interventions Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics

10. Peripheral Interventions Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Peripheral Interventions Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Peripheral Interventions Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Peripheral Interventions Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Peripheral Interventions Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Peripheral Interventions Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Peripheral Interventions Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Boston Scientific
    • 11.2.3. Medtronic
    • 11.2.4. Cook Medical
    • 11.2.5. Cordis
    • 11.2.6. Terumo Corporation
    • 11.2.7. Johnson & Johnson
    • 11.2.8. Teleflex
    • 11.2.9. B. Braun Melsungen
    • 11.2.10. Penumbra, Inc.
    • 11.2.11. Endologix
    • 11.2.12. Merit Medical Systems
    • 11.2.13. Philips Healthcare
    • 11.2.14. AngioDynamics
    • 11.2.15. Siemens Healthineers
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us